Bank of America
NDRA icon

Bank of America’s ENDRA Life Sciences NDRA Stock Holding History

Bank of America’s Portfolio NDRA Stock Details NDRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10
Closed -$45 – 6483
2025
Q4 		$45 Buy
10
+4
+67% +$23 ﹤0.01% 6979
2025
Q3 		$32 Hold
6
– – ﹤0.01% 8100
2025
Q2 		$21 Buy
6
+2
+50% +$8 ﹤0.01% 8241
2025
Q1 		$16 Hold
4
– – ﹤0.01% 8165
2024
Q4 		$25 Buy
+4
New +$27 ﹤0.01% 7987
2024
Q3 		– Hold
0
– – – 8119
2024
Q2 		– Hold
0
– – – 8112
2023
Q1 		– Hold
0
– -$24 – 8116
2022
Q4 		– Hold
0
– – – 7948
2022
Q1 		– Hold
0
– – – 8581
2021
Q4 		– Hold
0
– – – 8490
2021
Q3 		– Hold
0
– – – 8290
2021
Q2 		– Hold
0
– – – 7966
2019
Q3 		– Hold
0
– – – 7408
2019
Q2 		– Hold
0
– – – 7335

Other funds holding NDRA

ACM
Altium Capital Management New York $42M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.99% 1-Year Est. Return

Bank of America's NDRA Position: Q1 2026 in Review

Bank of America sold out of ENDRA Life Sciences (NDRA) in Q1 2026, closing a stake of 10 shares — an estimated $45 sold.

Bank of America first reported a position in NDRA in Q4 2024 and held it in 5 quarters. The position peaked at $45 in Q4 2025. 8 funds tracked by Wall St. Rank hold NDRA as of Q1 2026.

  • Bank of America reported no remaining ENDRA Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 10 ENDRA Life Sciences shares in Q1 2026, an estimated $45.
  • Bank of America first reported a position in ENDRA Life Sciences in Q4 2024 and held it in 5 quarters.
  • Bank of America's ENDRA Life Sciences position peaked at $45 in Q4 2025.
  • 8 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.